Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

ForaCare Suisse AG Releases Rapid COVID-19 Antigen Test
  • USA - English


News provided by

ForaCare Suisse AG

07 Jan, 2021, 10:00 IST

Share this article

Share toX

Share this article

Share toX

Test Results in 15 Minutes, No Laboratory Processing Required, Highly Accurate & Reliable Results

ST. GALLEN, Switzerland, Jan. 7, 2021 /PRNewswire/ -- ForaCare Suisse AG announced the release of its antigen test, FORA COVID-19 Antigen Rapid Test, that provides fast, accurate and easy-to-interpret test results. The test can be administered by trained professionals and doesn't rely on laboratory-processing. 

Approved by Swissmedic, the FORA COVID-19 Antigen Rapid Test is a diagnostic antigen test for the direct detection of an acute infection with SARS-CoV-2, the respiratory virus caused by the novel coronavirus.

The rapid test has been approved for distribution in Switzerland and its treaty countries without restriction. It is listed by the Federal Institute for Drugs and Medical Devices (BfArM) and is reimbursable in Germany.  

ForaCare's FORA COVID-19 Rapid Test was developed via a collaboration with Taiwan Academia Sinica, ranked by Reuter as one of the Top 20 "World's Most Innovative Research Institutions"1. Recent clinical study results demonstrated the FORA COVID-19 Rapid Test is accurate and reliable with a 95.8% sensitivity (Ct≤30) and a 98.6% specificity by testing 57 PCR-positive and 80 PCR-negative specimens.

"We are proud to offer trained testing professionals an alternative that allows them to make fast, accurate and reliable tests without waiting on outside laboratories to determine active virus," said Ty-Minh Tan, CEO of ForaCare Suisse AG.

The test kit packaging comes with everything necessary to administer a test for COVID-19 antigen and can determine if a person has an active COVID-19 infection. The test provides accurate results in 15 minutes. For more information, visit https://www.fora-antigen.com.

  1. Ewalt, David M. (2019, September 18). The World's Most Innovative Research Institutions 2019. Retrieved November 26, 2020, from http://www.reuters.com/innovation/most-innovative-institutions-2019

Contact: Elena Birrer 
+41-71-220-1001
E-mail: [email protected]
Website: http://www.foracare.ch/

Modal title

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.